Cargando…
Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity of TMAO. In this study, high-fat diet-fed ApoE-/- mice were treated with finasteride, ranitidine, and andrioe. Subsequ...
Autores principales: | Liu, Junfeng, Lai, Lingyun, Lin, Jiajia, Zheng, Jiajia, Nie, Xiaoli, Zhu, Xiaoye, Xue, Jun, Liu, Te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019130/ https://www.ncbi.nlm.nih.gov/pubmed/32071549 http://dx.doi.org/10.7150/ijbs.40934 |
Ejemplares similares
-
Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota
por: Wang, Zuoyuan, et al.
Publicado: (2022) -
Formation
Mechanism of NDMA from Ranitidine, Trimethylamine,
and Other Tertiary Amines during Chloramination: A Computational Study
por: Liu, Yong Dong, et al.
Publicado: (2014) -
Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
por: Tan, Chuhong, et al.
Publicado: (2020) -
Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018) -
Uncovering the trimethylamine-producing bacteria of the human gut microbiota
por: Rath, Silke, et al.
Publicado: (2017)